The resistance to sunitinib emerges through different mechanisms: the intrinsic resistance seems to be related to the primary redundancy of available angiogenic signals from the tumor, causing unresponsiveness to VEGF-targeted therapies [13]. This evidence concerns the gene VEGFA and neoplasm.